Back to Journals » Drug, Healthcare and Patient Safety » Call For Papers
Drug, Healthcare and Patient Safety
ISSN: 1179-1365
The following Article Collection/ Thematic Series is currently open for submissions:
Medication Safety in Geriatric Populations
Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in Drug, Healthcare and Patient Safety on "Medication Safety in Geriatric Populations". The Collection is led by the Editor-in-Chief, Professor Rajender Aparasu.
With the increase in older adults globally, there is a greater need to understand medication safety issues, as older adults are often excluded in randomized trials. In addition, the complexity of chronic care for older adults often leads to polypharmacy and potentially inappropriate medication use, which can result in drug-induced diseases, adverse drug reactions, drug interactions, cognitive impairment, falls, hospitalization, and mortality. This Article Collection aims to address these challenges by bringing together the latest research and clinical insights to improve medication safety in geriatric populations.
Medication safety is crucial in geriatric populations due to the increased susceptibility of older adults to adverse drug reactions and the potential for drug interactions. The aging process can alter pharmacokinetics and pharmacodynamics, making older adults more prone to medication-related problems. Ensuring medication safety in this vulnerable population is essential to prevent medication-related morbidity and mortality and associated healthcare burden such as hospitalization, healthcare costs, and health-related quality of life for older adults.
To help raise the profile of this important area of research, Drug Healthcare and Patient Safety is publishing a timely Article Collection on medication safety in geriatric populations.
Potential topics include, but are not limited to, the following:
1. Medicated-related problems in older adults
2. Polypharmacy and Medication Management
3. Inappropriate Medication Use
4. Drug-drug and Drug-disease Interactions
5. Prescribing Cascade and Deprescribin
All manuscripts submitted to this Article Collection will undergo desk assessment and peer review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are existing members of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.
The deadline for submissions is 31 December 2025.
Please submit your manuscript on our website, quoting the promo code IXNYV for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.
Call For Papers
Editor-in-Chief: Professor Rajender Aparasu
To see where Drug, Healthcare and Patient Safety is indexed online view the Journal Metrics.
What is the advantage to you of publishing in Drug, Healthcare and Patient Safety?
- It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.
- Although Drug, Healthcare and Patient Safety receives many papers, unlike most traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
- The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. Drug, Healthcare and Patient Safety has a quicker turnaround time than this. Generally peer review is complete within 3-4 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 6 weeks for first editorial decision.
- Many authors have found that our peer reviewer’s comments substantially add to their final papers.
To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution an article publishing charge.
PubMed Central
Drug, Healthcare and Patient Safety is indexed on PubMed Central (title abbreviation: Drug Healthc Patient Saf). All published papers in this journal are submitted to PubMed for indexing straight away.
Become a Favored Author and receive real benefits
If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so. Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee.
Click here to go through to the Favored Author signup page.
Yours sincerely
Professor Rajender Aparasu
Editor-in-Chief
Drug, Healthcare and Patient Safety
Email: Editor-in-Chief
Updated 11 October 2022
Related journals you may also be interested in:
- Adolescent Health, Medicine and Therapeutics
- Biologics: Targets and Therapy
- Clinical Audit
- Clinical Interventions in Aging
- Clinical Pharmacology: Advances and Applications
- ClinicoEconomics and Outcomes Research
- Drug Design, Development and Therapy
- ImmunoTargets and Therapy
- Integrated Pharmacy Research and Practice
- International Journal of Nanomedicine
- Journal of Experimental Pharmacology
- Open Access Journal of Clinical Trials
- Patient Preference and Adherence
- Patient Related Outcome Measures
- Pharmacogenomics and Personalized Medicine
- Pragmatic and Observational Research
- Psychology Research and Behavior Management
- Therapeutics and Clinical Risk Management
- Vascular Health and Risk Management